BioCells MedicalBioCells Medical
Request Consultation
BioCells MedicalBioCells Medical

European private clinic specialising in personalised T-reg, stem cell and regenerative therapy. Warsaw, Poland. Since 2013.

info@biocellsmedical.com

Treatment Programs

  • Amyotrophic Lateral Sclerosis (ALS)
  • Multiple Sclerosis (MS)
  • Parkinson’s Disease
  • Multiple System Atrophy (MSA)
  • Peripheral Neuropathy
  • Muscular Dystrophy
  • Autism Spectrum Disorder (ASD)
  • Cerebral Palsy
  • All Diagnoses →

About

  • Medical Team
  • Philosophy
  • Clinical Data
  • FAQ

Contact

+48 22 307 48 82(EN/RU/PL)

+39 392 995 41 31(IT)

+33 4 23 11 00 21(FR)

Locations

By appointment only

Franciszka Klimczaka 8A, 02-797 Warsaw, Poland

Research center

75 Kneeland Street, 14th Floor, Boston MA 02111, USA

© 2013–2026 BIOCELLS MEDICAL Sp. z o.o. | KRS: 0001099454 | NIP: 1133130802

Privacy PolicyCookie PolicyChild Protection Policy

CHRONIC NERVE ROOT COMPRESSION · SCIATICA · CERVICAL RADICULOPATHY

Chronic Radiculopathy: Personalised Cellular Therapy

A physician-led, laboratory-verified treatment programme targeting the biological mechanisms behind chronic nerve root compression — designed to reduce pain, restore limb function and decrease medication dependency, based on each patient’s anatomy, pain profile and clinical history.

Request Medical Consultation
  1. Home
  2. /Treatment Programs
  3. /Chronic Radiculopathy: Personalised Cellular Therapy

About the Condition

What is Chronic Radiculopathy?

Radiculopathy is a clinical condition caused by compression, inflammation or injury to a spinal nerve root. When a nerve root is compromised — typically by a herniated disc, spinal stenosis, or degenerative foraminal narrowing — the result is radiating pain, numbness, tingling or weakness along the nerve’s distribution in the arm or leg.

The condition becomes chronic when symptoms persist beyond 12 weeks despite conservative management. At this stage, the pathology involves not only ongoing mechanical compression but also perineural fibrosis (scarring around the nerve root), dorsal root ganglion sensitisation and neuroinflammatory changes that perpetuate pain even after the original structural problem has partially resolved.

Chronic radiculopathy affects a significant proportion of patients with disc disease and spinal stenosis. Surgical decompression provides relief in many cases, but a substantial subset of patients continues to experience pain and functional limitation after surgery — a phenomenon known as Failed Back Surgery Syndrome (FBSS). Our programme addresses the biological component of chronic radiculopathy that structural intervention alone cannot resolve.

01

Lumbar Radiculopathy (Sciatica)

The most common form. Compression of the L4, L5 or S1 nerve roots produces pain radiating from the lower back through the buttock and into the leg. Often caused by lumbar disc herniation or foraminal stenosis. Symptoms include leg pain, numbness in the foot or calf, and weakness during walking or standing.

02

Cervical Radiculopathy

Compression of nerve roots in the neck (C5–C8), producing pain, numbness or weakness radiating into the shoulder, arm and hand. Frequently caused by cervical disc herniation or spondylotic foraminal narrowing. Patients often report difficulty gripping objects, shoulder blade pain and hand numbness.

03

Thoracic Radiculopathy

A rare form affecting nerve roots in the mid-spine. Produces band-like pain around the chest or abdomen. Often misdiagnosed as cardiac or abdominal pathology. Usually associated with thoracic disc disease, vertebral fracture or post-herpetic neuralgia.

04

Post-surgical Failed Back Syndrome

Persistent or recurrent radicular pain following spinal surgery (laminectomy, discectomy, fusion). Caused by epidural fibrosis, recurrent disc herniation, adjacent segment disease or incomplete nerve root decompression. Affects 10–40% of patients after lumbar spine surgery. Often the most treatment-resistant subtype.

Our program is individually adapted for all subtypes and all stages of progression.

Important: Each patient is accepted into the programme only after a comprehensive individual medical assessment, which evaluates the anatomical level of nerve root involvement, chronicity of symptoms, prior interventions and overall pain profile.

Clinical Outcomes

Results From
Our Registry

The following data are derived from structured observational analysis of patients treated at BioCells Medical between 2017 and 2025. All figures represent aggregated clinical registry outcomes with longitudinal follow-up. These are observational results — not randomised controlled trial data — and do not constitute a guarantee of therapeutic effect.

38

chronic radiculopathy patients treated since 2013

78%

measurable functional stabilisation on VAS at 3–6 months

−2.8 pts

average VAS score change at 6 months — vs. expected +0.3 pts natural progression

68%

sustained functional stability with average 2 years of follow-up

80%

showed improvement in one or more measured domains

75%

retained independence in basic activities of daily living (ADL) at 12 months

Key Functional Improvements Observed

Pain (radiating leg or arm pain during daily activity, nocturnal pain, opioid or neuropathic medication use)

78%

Mobility & function (walking tolerance, standing endurance, grip strength and fine motor control)

72%

Structural (imaging: neural foraminal status, nerve root inflammation)

62%

Quality of life (sleep, daily activity, work capacity)

74%

Observed Clinical Timeline

1–4 weeks

Initial clinical response

2–4 months

Clinically meaningful change

1–2 years onward

Long-term stability — continuous monitoring

Important: Outcomes depend on the anatomical level of compression, chronicity of symptoms, number of prior interventions and individual biological response. Patients with Failed Back Surgery Syndrome and extensive epidural fibrosis may respond more gradually.

Find out if our program can help in your specific case. The initial medical consultation is free and carries no obligation.

Request Consultation

The BioCells Program

How We Treat
Five-Component Protocol

Our radiculopathy programme combines five biological components into a single personalised protocol. No two protocols are identical — each is constructed following a detailed medical evaluation of the patient’s imaging, pain profile, nerve conduction data and clinical priorities.

Minimally invasive administration

Treatment is delivered by intravenous infusion or targeted local injection — not surgical instruments. No incisions, no hardware, no hospitalisation.

No general anaesthesia

Avoids the risks and recovery time associated with anaesthesia. Particularly relevant for patients who have already undergone one or more spinal procedures.

No risk of immune rejection

MSCs are immunoprivileged: they express low levels of HLA-I, lack HLA-II and carry a minimal risk of rejection whether the protocol is autologous or allogeneic. Allogeneic MSC protocols do not require immunosuppression.

Targets the biological drivers of chronic pain

Rather than masking pain pharmacologically, our protocol targets neuroinflammation, perineural fibrosis and dorsal root ganglion sensitisation — the mechanisms that sustain chronic radicular pain.

Complements existing treatment

Our programme is compatible with current pain medication, physiotherapy and prior surgical interventions. Patients do not need to discontinue existing treatment before commencing our protocol.

Patients from around the world

We work with patients from around the world. Airport transfers, accommodation, visa support and multilingual coordination are included in every treatment programme.

What It Is

T-regs are specialised immune cells that naturally suppress destructive inflammatory processes. They are the immune system’s built-in mechanism for preventing excessive tissue damage from chronic immune activation.

How It Is Done

Delivered autologously (from the patient’s own blood) or allogeneically (from a certified donor), based on the patient’s immune status and clinical assessment. Preparation and quality testing performed in our Warsaw laboratory.

Biological Mechanisms

  • Suppress chronic immune-mediated inflammation around the nerve root
  • Reduce dorsal root ganglion sensitisation driven by inflammatory mediators
  • Restore balanced immune regulation in the affected spinal segment

How This Helps in Chronic Radiculopathy

Chronic radiculopathy involves persistent immune-mediated inflammation at the nerve root level. Pro-inflammatory cytokines sensitise the dorsal root ganglion, amplifying pain signals and maintaining the chronic pain state. T-regs directly counteract this by suppressing the immune-driven component of nerve root irritation, reducing the biological amplification of pain.

Your Medical Board

The exact combination, dosage, sequencing and delivery method of all five components is determined individually by our medical board for each patient. No two treatment protocols are identical. Your programme is constructed based on your specific diagnosis, affected spinal level, chronicity, prior interventions and clinical priorities.

Your protocol is designed individually. Speak with our medical team to understand what your personalised program would include.

Request Consultation

Patient Journey

Your Treatment Journey
Step by Step

01

Free Medical Consultation

Your case is reviewed remotely by our physician team. We assess your diagnosis, imaging, pain history and treatment goals. This consultation is free and carries no obligation.

02

Medical Eligibility Assessment

A detailed review of all medical documentation, MRI/CT imaging and nerve conduction studies. Our medical board evaluates eligibility, confirms safety parameters and designs your personalised therapeutic protocol.

03

Laboratory Preparation

Your cells are collected, isolated, expanded and quality-tested in our certified Warsaw laboratory. Each batch receives a full traceability certificate. This stage typically takes 2–3 weeks.

04

Treatment Administration

Cells are delivered by intravenous infusion or targeted local administration — no surgery, no general anaesthesia. Airport transfers, accommodation and visa support are included in the programme for international patients.

05

Supervised Rehabilitation

Structured rehabilitation sessions with our specialist, adapted to your pain level, spinal condition and functional goals. Includes spinal stabilisation, neural mobilisation and graded return to activity. Available at our clinic or remotely coordinated with your local physiotherapist.

06

Long-Term Medical Follow-Up

Your dedicated coordinator monitors pain levels, functional progress and medication usage. A medical-grade wearable bracelet supports continuous health tracking regardless of your location.

01

Free Medical Consultation

Your case is reviewed remotely by our physician team. We assess your diagnosis, imaging, pain history and treatment goals. This consultation is free and carries no obligation.

02

Medical Eligibility Assessment

A detailed review of all medical documentation, MRI/CT imaging and nerve conduction studies. Our medical board evaluates eligibility, confirms safety parameters and designs your personalised therapeutic protocol.

03

Laboratory Preparation

Your cells are collected, isolated, expanded and quality-tested in our certified Warsaw laboratory. Each batch receives a full traceability certificate. This stage typically takes 2–3 weeks.

04

Treatment Administration

Cells are delivered by intravenous infusion or targeted local administration — no surgery, no general anaesthesia. Airport transfers, accommodation and visa support are included in the programme for international patients.

05

Supervised Rehabilitation

Structured rehabilitation sessions with our specialist, adapted to your pain level, spinal condition and functional goals. Includes spinal stabilisation, neural mobilisation and graded return to activity. Available at our clinic or remotely coordinated with your local physiotherapist.

06

Long-Term Medical Follow-Up

Your dedicated coordinator monitors pain levels, functional progress and medication usage. A medical-grade wearable bracelet supports continuous health tracking regardless of your location.

The first step is free. Request a medical consultation and our medical consultant will contact you within 24 hours.

Request Consultation

Safety Profile

Safety, Eligibility
and Contraindications

Cellular therapy is considered safe when delivered under proper medical supervision and according to validated protocols. In our practice, the procedure is well-tolerated by the majority of chronic pain patients.

Temporary mild reactions — such as transient local discomfort at the injection site, mild fatigue or a temporary increase in pain sensitivity — may occur in a minority of patients. These are typically short-lived and resolve within 48–72 hours.

A final medical assessment is performed on-site before every treatment session. If a patient’s status has changed — including acute disc extrusion with cauda equina signs — the programme may be temporarily modified or postponed for safety reasons.

All contraindications are evaluated individually. A contraindication in one clinical context does not necessarily preclude treatment in a different context — this is always determined by physician assessment.

Standard Contraindications

Active acute infection or fever

Active malignancy or ongoing chemotherapy / radiotherapy

Severe decompensated cardiac or renal failure

Pregnancy

Post-Treatment

After Treatment
and Follow-Up

01

Dedicated pain management coordinator

monitors pain scores, functional milestones and medication adjustments

02

Personalised spinal rehabilitation programme

neural mobilisation, core stabilisation and graded activity progression

03

Medical-grade wearable monitoring

continuous activity and sleep data supporting clinical decision-making

04

Long-term coordinator support

proactive check-ins, clinical guidance and response to any changes in pain status

05

Continued clinical access

our medical team remains available for ongoing reassessment and protocol adjustment

Nerve root recovery is a gradual biological process. Clinical response timelines vary depending on the degree of nerve damage, duration of compression and extent of perineural fibrosis. The post-treatment monitoring period is medically essential — it allows us to track response, adjust rehabilitation and determine whether additional intervention is indicated.

Patient Stories

What Our Patients Say

01 / 05

“Three years of sciatica, two epidural injections, daily medication. After the treatment in Warsaw I noticed the leg pain dropping off around week three. By the second month I could walk to the shops without stopping. I have cut my medication in half and my GP is genuinely impressed with how much has changed.”

Patient

Lumbar radiculopathy (L5–S1) · United Kingdom

Every case is assessed individually by our physician team. Request a consultation to discuss your specific situation with our physician team.

Request Consultation

Patient Cases

Clinical Observations

Documented treatment outcomes recorded by the BioCells Medical team after personalised regenerative medicine protocols.

All cases →
ALS — Regained Movements and Improved Swallowing
Neurological·July 2025

ALS — Regained Movements and Improved Swallowing

Amyotrophic Lateral Sclerosis

Ilaria Baldi · Italy→
Parkinsonism — Reduced Rigidity, Improved Walking and Clearer Speech
Neurological·March 2025

Parkinsonism — Reduced Rigidity, Improved Walking and Clearer Speech

Parkinsonism

Franco Bonifazi · Italy→
COPD — Improved Breathing Capacity and Physical Endurance
Respiratory·September 2024

COPD — Improved Breathing Capacity and Physical Endurance

Chronic Obstructive Pulmonary Disease

Pier Giorgio · Italy→
Multiple Sclerosis — Regained Strength and Restored Independence
Neurological·May 2024

Multiple Sclerosis — Regained Strength and Restored Independence

Secondary Progressive Multiple Sclerosis (SPMS)

Silvia Baistrocchi · Italy→

Get Started

Take the First Step

If you or someone close to you has been living with chronic radiculopathy, sciatica or persistent pain after spinal surgery, our medical team is available for a free, no-obligation medical consultation — based on your diagnosis, imaging and individual clinical profile.

We review every inquiry personally. You will speak with a physician, not an administrator.

01

Submit your case online or by phone

02

Our medical consultant contacts you to review your documents

03

The medical board presents your personalised treatment plan

Request a Consultation

Tell us about your condition. Our medical consultant will contact you within 24 hours to review your documents.

Open Consultation Form
info@biocellsmedical.com
+48 22 307 48 82EN / RU / PL+44 20 8073 1427UK+39 392 995 41 31IT+33 4 23 11 00 21FR

Multilingual coordination — English, Italian, French, Russian, Polish

Evidence Base

Scientific References
and Clinical Trials

Our clinical approach is informed by and consistent with published research in the field of regenerative medicine.

Treatment of Lumbar Degenerative Disc Disease-Associated Radicular Pain with Culture-Expanded Autologous Mesenchymal Stem Cells: A Pilot Study on Safety and Efficacy

pubmed.ncbi.nlm.nih.gov/28938891/

↗

Intradiscal Mesenchymal Stromal Cell Therapy for the Treatment of Low Back Pain Due to Moderate-to-Advanced Multilevel Disc Degeneration: A Phase IIB Randomized Clinical Trial (DREAM Study)

pmc.ncbi.nlm.nih.gov/articles/PMC12129703/

↗

Mesenchymal Stem Cells Can Improve Discogenic Pain in Patients with Intervertebral Disc Degeneration: A Systematic Review and Meta-Analysis

pmc.ncbi.nlm.nih.gov/articles/PMC10313064/

↗

First Human Report of Relief of Lumbar and Cervical Discogenic and Arthritic Back Pain After Epidural and Facet Joint Mesenchymal Stem Cell Injection: A Case Report

pubmed.ncbi.nlm.nih.gov/35762554/

↗

Cellular and Exosome-based Therapies in Neuroinflammatory Syndromes (NCT07145502)

clinicaltrials.gov/study/NCT07145502

↗